Valbiotis SA (FR:ALVAL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Valbiotis, a French company focused on developing dietary supplements for metabolic disorder prevention and management, reported that its Annual General Meeting took place on June 25, 2024, in La Rochelle, with mixed outcomes for the resolutions presented. While resolutions 1 to 4 and 17 were approved by shareholders, resolutions 5 to 16 were not passed. The company, known for its partnerships and support from the BPI network and the European Union, continues to aim for innovation in health nutrition products.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.